4/25
02:35 pm
bmy
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]
Low
Report
Bristol Myers Squibb Swings To Quarterly Loss, After String Of Multi-Billion Acquisitions [Yahoo! Finance]
4/25
01:40 pm
bmy
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]
Low
Report
Bristol-Myers (BMY) Q1 Loss Narrower Than Expected, Sales Beat [Yahoo! Finance]
4/25
12:03 pm
bmy
Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]
Low
Report
Why Bristol Myers Squibb Stock Is Sinking Today [Yahoo! Finance]
4/25
11:44 am
bmy
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
Low
Report
Bristol Myers (BMY) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates [Yahoo! Finance]
4/25
11:44 am
bmy
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
4/25
10:53 am
bmy
Is Bristol Myers Squibb Stock a Millionaire Maker? [Yahoo! Finance]
Low
Report
Is Bristol Myers Squibb Stock a Millionaire Maker? [Yahoo! Finance]
4/25
08:56 am
bmy
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18 [Yahoo! Finance]
Low
Report
International Myeloma Foundation Holds 15th Annual Gala at the Edison Ballroom in New York City on April 18 [Yahoo! Finance]
4/25
07:02 am
bmy
Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [Seeking Alpha]
Medium
Report
Bristol-Myers Squibb Company Non-GAAP EPS of -$4.40 beats by $0.02, revenue of $11.78B beats by $330M [Seeking Alpha]
4/25
06:59 am
bmy
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
Medium
Report
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
4/24
10:15 am
bmy
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting [Yahoo! Finance]
Low
Report
Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting [Yahoo! Finance]
4/24
09:12 am
bmy
Overhaul Unites Supply Chain Leaders with New Partner Ecosystem Program to Combat Global Cargo Theft [Yahoo! Finance]
Low
Report
Overhaul Unites Supply Chain Leaders with New Partner Ecosystem Program to Combat Global Cargo Theft [Yahoo! Finance]
4/24
08:07 am
bmy
The Galien Foundation Announces 2024 Prix Galien International Awards Nominees [Yahoo! Finance]
Low
Report
The Galien Foundation Announces 2024 Prix Galien International Awards Nominees [Yahoo! Finance]
4/22
05:13 pm
bmy
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
Low
Report
Alexandria Real Estate's Q1 FFO rises on stronger occupancy rates [Yahoo! Finance]
4/22
03:58 pm
bmy
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
Neutral
Report
Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know [Yahoo! Finance]
4/22
10:56 am
bmy
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
Low
Report
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics [Yahoo! Finance]
4/22
09:58 am
bmy
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
Low
Report
Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal [Seeking Alpha]
4/22
09:46 am
bmy
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]
Neutral
Report
Interstitial Lung Disease Pipeline Research 2024: Therapeutic Assessment of 120+ Pipeline Drugs [Yahoo! Finance]
4/22
07:15 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster [Yahoo! Finance]
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster [Yahoo! Finance]
4/22
07:15 am
bmy
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer [Yahoo! Finance]
Low
Report
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer [Yahoo! Finance]
4/22
06:59 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
4/22
06:59 am
bmy
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Low
Report
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
4/21
08:31 am
bmy
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt? [Yahoo! Finance]
Low
Report
Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt? [Yahoo! Finance]
4/20
05:25 am
bmy
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations [Yahoo! Finance]
Low
Report
3 High-Yielding Dividend Stocks That Are Trading at Dirt-Cheap Valuations [Yahoo! Finance]
4/19
11:53 am
bmy
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies [Yahoo! Finance]
Low
Report
FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies [Yahoo! Finance]
4/19
06:14 am
bmy
FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk [Seeking Alpha]
Low
Report
FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk [Seeking Alpha]